Pacific Capital Partners Ltd Sells 44,750 Shares of ICU Medical, Inc. $ICUI

Pacific Capital Partners Ltd lowered its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 71.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,750 shares of the medical instruments supplier’s stock after selling 44,750 shares during the quarter. ICU Medical accounts for 2.7% of Pacific Capital Partners Ltd’s portfolio, making the stock its 18th biggest holding. Pacific Capital Partners Ltd owned about 0.07% of ICU Medical worth $2,532,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Arizona State Retirement System lifted its position in shares of ICU Medical by 1.3% during the third quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock worth $828,000 after purchasing an additional 91 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of ICU Medical by 11.6% in the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares during the last quarter. BNP Paribas Financial Markets increased its stake in ICU Medical by 4.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 2,459 shares of the medical instruments supplier’s stock worth $325,000 after buying an additional 107 shares during the period. Thrivent Financial for Lutherans lifted its holdings in ICU Medical by 0.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 18,098 shares of the medical instruments supplier’s stock valued at $2,392,000 after buying an additional 114 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in ICU Medical by 0.4% in the 3rd quarter. Alliancebernstein L.P. now owns 27,429 shares of the medical instruments supplier’s stock valued at $3,290,000 after buying an additional 116 shares during the period. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Up 1.0%

Shares of ICU Medical stock opened at $125.38 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.39 and a quick ratio of 1.15. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of 6,272.14, a PEG ratio of 1.79 and a beta of 0.79. The firm’s 50-day moving average is $142.73 and its two-hundred day moving average is $138.04. ICU Medical, Inc. has a 1 year low of $107.00 and a 1 year high of $160.29.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 EPS for the quarter, beating the consensus estimate of $1.68 by $0.23. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. The business had revenue of $535.94 million during the quarter, compared to analyst estimates of $541.20 million. During the same quarter in the previous year, the business posted $2.11 EPS. The company’s quarterly revenue was down 14.1% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, research analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ICUI has been the topic of a number of research analyst reports. Piper Sandler upped their target price on shares of ICU Medical from $172.00 to $178.00 and gave the stock an “overweight” rating in a research note on Friday, February 20th. KeyCorp boosted their price target on ICU Medical from $175.00 to $180.00 and gave the company an “overweight” rating in a report on Friday, February 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. Finally, Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, ICU Medical currently has a consensus rating of “Moderate Buy” and an average price target of $179.33.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.